MUROMACHI CHEMICALS INC.

4885・Standard Market・Pharmaceuticals

Official website

MUROMACHI CHEMICALS INC.

4885・Standard Market・Pharmaceuticals

Official website

MUROMACHI CHEMICALS INC.4885

Reference Indicators

Market Cap

37¥100M

P/E (Forecast)

—

P/B

1.4x

Dividend Yield (Forecast)

2.89%

ROE

6.5%

EV/EBITDA

4.1x

Financial Summary

Unit: ¥M

Item	2022May 2022	2023May 2023	2024May 2024	2025May 2025	2026May 2026
Net Sales	5,681	6,291	6,369	6,653	7,840
Cost of Sales	3,948	4,539	4,514	4,692	5,483
Gross Profit	1,732	1,752	1,854	1,960	2,357
SG&A Expenses	1,295	1,382	1,432	1,528	1,614
Operating Income	437	369	421	432	742
Non-operating Income	10	12	26	30	25
Non-operating Expenses	24	31	19	32	60
Ordinary Income	423	350	428	430	707
Extraordinary Income	3	0	41	0	20
Extraordinary Losses	1	0	0	81	399
Pre-tax Income	425	350	468	350	328
Income Taxes	-30	94	138	108	165
Net Income	456	256	330	241	163
EBITDA	538	491	558	593	933
Gross Margin	30.5%	27.8%	29.1%	29.5%	30.1%
Operating Margin	7.7%	5.9%	6.6%	6.5%	9.5%
ROA	9.5%	5.2%	6.5%	4.6%	2.6%
ROE	30.3%	13.5%	15.8%	10.2%	6.5%

Segment Performance

Unit: ¥M

2025

Segment	Net Sales	Operating Income	Operating Margin
医薬品事業	3,217	473	14.7%
健康食品事業	1,043	-98	-9.4%
化学品事業	2,391	57	2.4%
その他	0	0	0.0%